Public Health and Private Profits Under COVID-19 Pandemic
More discussion of how the private sector is undermining responses to Covid-19.
Read more...More discussion of how the private sector is undermining responses to Covid-19.
Read more...The coronavirus crisis will exacerbate an existing threat to healthcare systems, around the world: the problem of antibiotic resistance.
Read more...Coronavirus is exposing the severity of inequality in the US, particulary limited access to health care and the health costs of poverty.
Read more...Why we aren’t even at the end of the beginning of coronavirus-induced change.
Read more...Contrary to pharmaceutical company claims, revenue from high insulin prices are going to shareholders, not R&D
Read more...The supposed irresistable force of the economy is losing out to the immovable object of the coronavirus.
Read more...Coronavirus is smashing up the economic and political order. What sort of world comes next?
Read more...Some spots in America are staring to get serious about contact tracing to limit coronavirus spread. But can they commit the resources?
Read more...A look at promising Covid-19 test methods, and why diagnosis approaches may wind up differing across countries.
Read more...Scientific publishing is already suffering a quality control crisis, so it’s important to give a hard look at often-rushed coronavirus studies.
Read more...Will the disruption of Covid-19 deal a major blow to market ideology?
Read more...Unregulated assisted living facilities are becoming hotbeds of coronavirus cases.
Read more...The handling of the dead is a major but not much discussed challenge with coronavirus.
Read more...On the large gap between what the public and the scientific/medical community think about Covid-19 immunity, including testing for it.
Read more...It would be nice to go back to something like the old normal. But the coronavirus is still very much in charge.
Read more...